Close Window

Digital Look Email A Friend

AstraZeneca's inflammatory disease drug Fasenra approved in the US

Published by Benjamin Chiou on 18th September 2024

(Sharecast News) - AstraZeneca has received the green light for its Fasenra drug in the US, used to treat patients with a rare inflammatory disease.

URL: http://www.digitallook.com/dl/news/story/34562850/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.